Home' Australian Pharmacist : Australian Pharmacist June 2012 Contents Australian Pharmacist June 2012 I ©Pharmaceutical Society of Australia Ltd. 477
Continuing Professional Development
Submit your answers online at www.psa.org.au and receive automatic feedback
SUPPORTING PHARMACY PRACTICE
Under the Fifth Community Pharmacy
Agreement, the issue of post hospital
discharge review is recognised as a key area
for improvement. This can have a signi cant
impact on outcomes for consumers.
For consumers using DAAs, it is vital to
ensure that communication between the
hospital, the community pharmacy and the
GP occurs. When changes to medications
occur in hospital, the community pharmacy
needs to be sure that these changes are
re ected in the future DAAs provided
to the consumer and that the GP is
aware of the changes that have been
made and the reasons for the changes.
Professional services such as medication
pro les, HMRs and Medscheck are all
valid considerations which can assist with
medication management at this critical time
and can be used to ensure that changes
to medicines are communicated to all the
necessary members of the health care team.
Pharmacists should routinely assess
DAA preparation, adherence and ability
to manage medicines using the DAA
according to guidelines and standards.
Working and communicating with
consumers, GPs and other health care
providers is essential for ful lling PPI
commitments and the ongoing success of
the DAA as an adherence aid.
The pharmacist has an important role in
the continuity of care. Achieving continuity
in medication management involves
commitment, cooperation and coordination
among all partners in a consumer's health
care team. At all times it is essential to
maintain a patient-centred care approach.
Key learning points
• Patient-centred care is essential to enable
you to comply with professional and
ethical practice requirements.
• The health bene ts of assisting
adherence through comprehensive
medication management activities are
• The bene ts to the pharmacy and
opportunities through the provision of
professional services including DAAs
should not be underestimated.
• Planning for success, thorough
evaluation and measuring success are
important for all professional services.
• Guidelines and standards for pharmacists
-- dose administration aids service:
• Provision of medication pro les: www.
• Working with others: www.psa.org.au/
• Medscheck: www.5cpa.com.au/
• APAC Guiding principles to achieve
continuity in medication management:
• APAC Guiding principles for medication
management in the community: www.
• Claiming and payment: www.5cpa.
1. Pharmaceutical Society of Australia. Guidelines and standards
for pharmacists -- dose administration aids service. Jul 2007.
2. Pharmaceutical Society of Australia. Guidelines and standards
for pharmacists -- medication profiling service. Oct 2007.
3. Jackson S, Naunton M, Peterson G. Essential CPE -- medication
adherence. Canberra: Pharmaceutical Society of Australia;
4. Ostberg L, Blaschke T. Adherence to medication. N Engl J Med.
5. Annabel B, Roberts A. Business management and professional
services. Proceedings of Pharmacy Australia Congress: 6--9 Oct
2011, Melbourne, Australia.
6. Pharmaceutical Society of Australia. Professional Practice
Standards Version 4. 2010.
7. Pharmacy Guild of Australia. Pharmacy practice incentives
factsheet -- primary health care basics [online]. At: www.5cpa.
8. Department of Veterans' Affairs. Dose administration aid
service -- information for pharmacists [online]. At: www.dva.
9. Pharmacy Guild of Australia. Pharmacy practice incentives
factsheet -- working with others basics [online]. At: www.5cpa.
1. Which of the following consumers
is MOST LIKELY to bene t from a
a) Mary, a 45-year-old woman who takes
omeprazole 20 mg tablets at night.
b) Joseph, a 26-year-old man who takes
risperidone 4 mg and amitriptyline 25
mg at night.
c) Julianne, a 16-year-old girl who takes
the oral contraceptive pill.
d) John, a 52-year-old man who takes
allopurinol 300 mg daily.
2. People who use DAAs are unlikely
to need any further assistance with
adherence to medicines.
3. Which of the following bene ts of
DAAs is likely to improve outcomes
for the pharmacy?
a) Decreased incidence of adverse
e ects related to medication
b) Reduced hoarding of medicines.
c) Decreased hospitalisation as a result of
d) Regular communication between
health care professionals.
4. Which statement is INCORRECT?
a) Community and hospital pharmacists
have a duty of care to address
continuity of medication in a recently
b) DAA services include counselling and
c) DAA provision removes the consumer's
ability to self-manage their medicines.
d) For professional services to be
sustainable, the costs for providing the
service need to be adequately covered.
A score of 3 out of 4 attracts 1 CPD credit.
Links Archive Australian Pharmacist July 2012 Australian Pharmacist May 2012 Navigation Previous Page Next Page